© 2016

Non-coding RNAs in Colorectal Cancer

  • Ondrej Slaby
  • George A. Calin

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 937)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Non-coding RNAs: Biology and Implications in Colorectal Cancer Pathogenesis

    1. Front Matter
      Pages 1-1
    2. Sonja Hombach, Markus Kretz
      Pages 3-17
    3. Yinxue Yang, Yong Du, Xiaoming Liu, William C. Cho
      Pages 19-51
    4. Claire Josse, Vincent Bours
      Pages 53-69
    5. Daniele Fanale, Nadia Barraco, Angela Listì, Viviana Bazan, Antonio Russo
      Pages 93-108
    6. Sippy Kaur, Johanna E. Lotsari-Salomaa, Riitta Seppänen-Kaijansinkko, Päivi Peltomäki
      Pages 109-122
    7. Pavel Vodicka, Barbara Pardini, Veronika Vymetalkova, Alessio Naccarati
      Pages 123-149
  3. Non-coding RNAs: New Class of Biomarkers in Colorectal Cancer

    1. Front Matter
      Pages 151-151
    2. Manuela Ferracin, Laura Lupini, Alessandra Mangolini, Massimo Negrini
      Pages 171-181
  4. Non-coding RNAs: Therapeutic Targets and Colorectal Cancer Therapeutics

    1. Front Matter
      Pages 205-205
    2. Daniele Fanale, Marta Castiglia, Viviana Bazan, Antonio Russo
      Pages 207-228
    3. Hirofumi Yamamoto, Masaki Mori
      Pages 239-247
  5. Back Matter
    Pages 249-252

About this book


This is the first book to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of non-coding RNAs found to be associated with colorectal cancer pathogenesis. Readers will discover possible mechanisms underlying the substantial roles played by non-coding RNAs in molecular hallmarks of colorectal cancer.

This work further provides the comprehensive overview and novel insights into using of non-coding RNAs as colorectal cancer biomarkers enabling early detection of the disease, prognostic stratification of the patients and prediction of therapeutic response.

The reader is introduced to the overview of modern non-coding RNAs-based therapeutic strategies, and summary of their preclinical testing performed in colorectal cancer. The work is written for researchers who want to explore current state of the knowledge in this interesting field of molecular oncology. 


Non-coding RNAs biomarkers colorectal cancer long non-coding RNAs microRNAs pathogenesis therapy

Editors and affiliations

  • Ondrej Slaby
    • 1
  • George A. Calin
    • 2
  1. 1.Central European Institute of TechnologyMasaryk UniversityBrnoCzech Republic
  2. 2.Department of Experimental Therapeutics Division of Cancer MedicineThe University of Texas MD Anderson Cancer CenterHouston, TXUSA

About the editors

Ondrej Slaby obtained his PhD degree in Oncology at the Faculty of Medicine at Masaryk University in 2008, and Associate Professor of Biochemistry degree at the Faculty of Science at Masaryk University in Brno in 2012. He is currently working as scientific secretary at the Masaryk Memorial Cancer Institute in Brno and research group leader (Molecular Oncology II) at the Central European Institute of Technology (CEITEC) at Masaryk University, Brno, Czech Republic. Dr. Slaby has published extensively in the area of non-coding RNAs. He published more than sixty impacted papers and three scientific monographs. His main research interests are in the non-coding RNAs significance in solid cancer and their translational potential in diagnostics and as the therapeutic targets (Sum of the times cited: 1930, h-index 23). Dr. Slaby is a member of American Association of Cancer Research, European Association for Cancer Research, European Society for Translational Medicine, Czech Society of Oncology, Czech Society for Biochemistry and Molecular Biology (member of FEBS), and others. In 2009, dr. Slaby founded Cancer Biology Section of Czechoslovak Biological Society and in 2012 co-founded Neurooncological Section of Czech Oncological Society. In 2010 and 2012 received Award of Czech Oncological Society, in 2014 Award for Medical Research of Czech Minister of Health. He is a member of the editorial board of the World Journal of Gastroenterology, World journal of Gastrointestinal Oncology, Biomarker Research and Clinical Oncology. As a peer-reviewer collaborates with a number of respected scientific journals from the field, for instance Cancer Research, Science Reports, International Journal of Cancer, British Journal of Cancer, European Journal of Cancer, PLoS ONE, Cancer Letters, Oncology, Expert Review of Molecular Diagnostics, Biomarkers in Medicine, Current Pharmacogenomics and Personalized Medicine, Human Pathology, etc. and several international grant agencies (Association of International Cancer Research, HRB Irelnd, WellcomeTrust, ZonMw, etc.)  and charities. 

Bibliographic information

Industry Sectors
Health & Hospitals
Oncology & Hematology
Consumer Packaged Goods